Continue with FacebookLooking to list your PhD opportunities? Log in here.
We have 47 Queen’s University Belfast, School of Pharmacy PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships
Queen’s University Belfast, School of Pharmacy PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships
We have 47 Queen’s University Belfast, School of Pharmacy PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships
PhD saved successfully
Investigating the role of USP17 in EMT
USP17 is over-expressed in a range of primary tumours (NSCLC, breast, colorectal, cervical, ovarian, osteosarcoma) and its depletion blocks the growth, and migration, of cells from all of these cancer types. Read more
Investigating the role of the microbiome in infection and health outcomes following renal transplantation
Many infections and disease states are closely linked to associated microbiomes, either of the patient themselves or the surrounding clinical environment. Read more
Investigating the clinical and molecular significance of the microbiome in breast cancer
Breast Cancer (BC) is the most common cancer in the UK, accounting for 15% of new cancer cases. There is a significant unmet clinical need to understand why some cancers do not respond to treatment and what drives metastasis. Read more
High throughput screening models for intracellular delivery of antimicrobial nanotherapeutics
Fungal and bacterial infections contribute to over 7 million deaths yearly, affecting over 300 million people globally (. GAFFI. ). Read more
Enzyme-responsive peptide hydrogel as in situ forming long-acting drug delivery implants
One of the key issues in the treatment and prevention of disease is that patients struggle to adhere to the complex dosage regimens of therapies, which often require multiple dosing at very specific times each day. Read more
Enhancing Protein Thermal Stability for Melt Processing
Protein therapeutics are an important class of medicines with renowned efficacy in the treatment of several relevant disorders. Despite significant advantages, protein delivery remains a significant challenge. Read more
Digital design and advanced processing technologies for antimicrobial nanotherapeutics
Fungal and bacterial infections contribute to over 7 million deaths yearly, affecting over 300 million people globally (GAFFI). Read more
Dexamethasone-releasing cochlear implants for fibroblast growth inhibition
Cochlear implants are implanted electronic hearing device designed to produce useful hearing sensations to persons with severe to profound nerve deafness by electrically stimulating nerves inside the inner ear. Read more
Development of paediatric-centred anti-malaria nanotherapeutic formulations using an advanced continuous manufacturing technology
Malaria is a life-threatening infectious disease caused by the plasmodium protozoan parasite passed through the bites of infected female Anopheles mosquitoes. Read more
Development of Nanomaterials for Targeting the Bacteria–Host Interface in Cystic Fibrosis Airways
The attachment of Pseudomonas aeruginosa (PA) to the airway mucus in the lungs of people with cystic fibrosis (CF) represents an important step in airway colonization and the subsequent development of lung infection. Read more
Development of long-acting injectable (LAI) drug delivery systems to treat ocular diseases
Delivery of drug molecules to treat visually impairing ocular diseases that originate in the posterior segment of the eye, has been the most challenging task to the pharmaceutical scientists and retinal specialists. Read more
Development of carbohydrate-functionalised materials for detection and prevention of medical device-associated infections
Antibiotic-resistant bacteria are a growing problem in the 21st century, causing longer and more serious infections, and resulting in poor outcomes for vulnerable patients. Read more
Development of antifungal nanotherapeutics containing AmB+ drug combinations using an advanced continuous manufacturing technology
Each year there are more than 150 million severe cases of fungal infection that occur globally, resulting in significant mortality. Read more
Development of a multi-antigenic mRNA vaccine for Glioblastoma
Glioblastoma is an aggressive brain tumour with the median survival time of ~15 months and the 5 year survival rates for those over 50 at a mere 6% (American Cancer Society). Read more
Developing novel therapeutic strategies to better treat Triple Negative Breast Cancer
One in two people will develop cancer in their lifetime and it is a leading cause of death. While significant progress has been made in the treatment of some cancers, there still remain some forms of the disease with limited treatment options and poor outcome. Read more